Jörg Prof. Dr. Kreuter

Jörg Prof. Dr. Kreuter's AcademicInfluence.com Rankings

Chemistry

#3026

World Rank

#4006

Historical Rank

Nanotechnology

#94

World Rank

#94

Historical Rank

chemistry Degrees

Jörg Prof. Dr. Kreuter

Philosophy

#6316

World Rank

#9334

Historical Rank

Logic

#3492

World Rank

#4663

Historical Rank

philosophy Degrees

Download Badge

Chemistry
Philosophy

Why Is Jörg Prof. Dr. Kreuter Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jörg Prof. Dr. Kreuter's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Nanoparticulate systems for brain delivery of drugs. (2001) (1157)
Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier (2002) (730)
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles) (1995) (517)
Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). (2009) (511)
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles (1999) (508)
Transport of drugs across the blood-brain barrier by nanoparticles. (2012) (506)
Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles (2003) (459)
Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? (2014) (431)
Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles (2004) (422)
Nanoparticles--a historical perspective. (2007) (418)
Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. (2009) (378)
Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles (1997) (335)
Microspheres and nanoparticles used in ocular delivery systems (1995) (331)
Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles. (2004) (331)
Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. (2004) (322)
Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. (2007) (272)
Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters. (2010) (255)
Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain. (2007) (240)
Marine sponge collagen: isolation, characterization and effects on the skin parameters surface-pH, moisture and sebum. (2002) (214)
Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model (2012) (209)
Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes. (2005) (207)
Peroral administration of nanoparticles (1991) (203)
Nanoparticles and microparticles for drug and vaccine delivery. (1996) (200)
Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles (2004) (199)
Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes. (2005) (197)
Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB) (2011) (195)
Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma. (2002) (183)
Nanoparticle-based dmg delivery systems (1991) (182)
Highly Specific HER2-mediated Cellular Uptake of Antibody-modified Nanoparticles in Tumour Cells (2004) (182)
Polysorbate‐80 coating enhances uptake of polybutylcyanoacrylate (PBCA)‐nanoparticles by human and bovine primary brain capillary endothelial cells (2000) (175)
Human serum albumin-polyethylenimine nanoparticles for gene delivery. (2003) (161)
Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro (1996) (152)
Efficient Chemotherapy of Rat Glioblastoma Using Doxorubicin-Loaded PLGA Nanoparticles with Different Stabilizers (2011) (144)
Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB) (2013) (143)
Enhanced drug targeting by attachment of an anti alphav integrin antibody to doxorubicin loaded human serum albumin nanoparticles. (2010) (131)
Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles. (2008) (130)
Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats (2006) (125)
Incorporation of basic fibroblast growth factor into methylpyrrolidinone chitosan fleeces and determination of the in vitro release characteristics. (1994) (124)
New adjuvants on a polymethylmethacrylate base (1976) (120)
Phagocytosis of Nanoparticles by Human Immunodeficiency Virus (HlV)-Infected Macrophages: A Possibility for Antiviral Drug Targeting (1992) (119)
Functional Protein Delivery into Neurons Using Polymeric Nanoparticles* (2009) (119)
Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles. (2004) (117)
Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process. (2004) (115)
Physicochemical characterization of polyacrylic nanoparticles (1983) (114)
Uptake of surfactant-coated poly(methyl methacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayers (1994) (112)
Ocular disposition of poly-hexyl-2-cyano[3-14C]acrylate nanoparticles in the albino rabbit (1985) (106)
In vitro studies of poly(methyl methacrylate) adjuvants. (1976) (105)
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines. (2010) (105)
Histone deacetylase inhibitors suppress natural killer cell cytolytic activity (2007) (104)
Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain (2010) (103)
Transport of Drugs Across the Blood-Brain Barrier by Nanoparticles (2002) (102)
Antisense delivery using protamine-oligonucleotide particles. (2000) (101)
Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells. (2017) (100)
Distribution and elimination of poly(methyl-2-14C-methacrylate) nanoparticle radioactivity after injection in rats and mice. (1979) (100)
Use of nanoparticles for cerebral cancer. (2008) (99)
Studies on the transport pathway of PBCA nanoparticles in ocular tissues. (1991) (99)
Application of nanoparticles for the delivery of drugs to the brain (2005) (97)
Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells. (2011) (95)
Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model (2006) (92)
Drug targeting with nanoparticles (1994) (91)
The Blood-brain Barrier and Drug Delivery to the CNS (2000) (88)
Use of liposomes, viral capsids, and nanoparticles as DNA carriers (1991) (88)
Distribution and elimination of coated polymethyl [2-14C]methacrylate nanoparticles after intravenous injection in rats. (1984) (87)
Ocular drug delivery of progesterone using nanoparticles. (1986) (87)
Microparticles derived from marine sponge collagen (SCMPs): preparation, characterization and suitability for dermal delivery of all-trans retinol. (2002) (84)
Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury (2016) (83)
Evaluation of pilocarpine-loaded albumin particles as controlled drug delivery systems for the eye. II. Co-administration with bioadhesive and viscous polymers (1995) (79)
Body distribution of polysorbate‐80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats (2005) (78)
Ethylcellulose: a new type of emulsion stabilizer. (2003) (76)
Influence of hydrophobicity on the adjuvant effect of particulate polymeric adjuvants. (1988) (73)
Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier (2019) (71)
Adsorption of plasma proteins on uncoated PLGA nanoparticles. (2013) (71)
Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles (1994) (67)
Nanoparticulate Transport of Oximes over an In Vitro Blood-Brain Barrier Model (2010) (65)
A solid colloidal drug delivery system for the eye: encapsulation of pilocarpin in nanoparticles. (1986) (64)
Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: focus on cardio- and testicular toxicity. (2007) (61)
Preparation and characterization of marine sponge collagen nanoparticles and employment for the transdermal delivery of 17β-estradiol-hemihydrate (2009) (61)
Phagocytosis and degradation of human serum albumin microspheres and nanoparticles in human macrophages. (1994) (60)
Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles. (1994) (60)
Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotides. (1997) (60)
Nanoparticles as adjuvants for vaccines. (1995) (58)
Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects. (2009) (58)
Effect of liposomes on percutaneous penetration of lipophilic materials (1992) (58)
HI 6 human serum albumin nanoparticles--development and transport over an in vitro blood-brain barrier model. (2011) (57)
Effect of nonionic surfactants on transdermal drug delivery: I. Polysorbates (1991) (57)
Lymphatic Targeting of Polymeric Nanoparticles After Intraperitoneal Administration in Rats (1992) (57)
Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration. (2011) (57)
Comparative study on the cytostatic effects and the tissue distribution of 5-fluorouracil in a free form and bound to polybutylcyanoacrylate nanoparticles in sarcoma 180-bearing mice. (1983) (57)
Hydrocortisone delivery to healthy and inflamed eyes using a micellar polysorbate 80 solution or albumin nanoparticles (1994) (55)
Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells. (2010) (55)
Distribution and elimination of polymethyl methacrylate nanoparticles after peroral administration to rats. (1984) (55)
Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutylcyanoacrylate nanoparticles (1986) (54)
Possibilities of using nanoparticles as carriers for drugs and vaccines. (1988) (53)
Body distribution of free, liposomal and nanoparticle-associated mitoxantrone in B16-melanoma-bearing mice. (1997) (53)
Evaluation of pilocarpine-loaded albumin particles as drug delivery systems for controlled delivery in the eye. I: In vitro and in vivo characterisation (1994) (51)
Adsorption of monoclonal antibodies to polyhexylcyanoacrylate nanoparticles and subsequent immunospecific binding to tumour cells in vitro (1983) (50)
The Role of Serum Complement on the Organ Distribution of Intravenously Administered Poly (methyl methacrylate) Nanoparticles: Effects of Pre-Coating with Plasma and with Serum Complement (1996) (50)
Doxorubicin-loaded PLGA nanoparticles for the chemotherapy of glioblastomas: Towards the pharmaceutical development. (2019) (50)
Targeted diagnostic magnetic nanoparticles for medical imaging of pancreatic cancer. (2015) (48)
The use of new polymethylmethacrylate adjuvants for split influenza vaccines. (1976) (48)
Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part II: characterization of antisense oligonucleotides loaded copolymer nanoparticles. (1999) (48)
High antibody titres in mice with polymethylmethacrylate nanoparticles as adjuvant for HIV vaccines (1991) (47)
Distribution and elimination of poly(methyl methacrylate) nanoparticles after subcutaneous administration to rats. (1983) (47)
Radiation sterilisation of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles. (2008) (47)
Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays (2006) (47)
Pharmacokinetic and Pharmacodynamic Aspects of an Ophthalmic Pilocarpine Nanoparticle-Delivery-System (1994) (46)
Distribution of polyhexyl cyanoacrylate nanoparticles in nude mice bearing human osteosarcoma. (1986) (45)
Targeting by cmHsp70.1-antibody coated and survivin miRNA plasmid loaded nanoparticles to radiosensitize glioblastoma cells. (2013) (44)
Effect of nanoparticles on transdermal drug delivery. (1991) (44)
Influence of Surface-Modifying Surfactants on the Pharmacokinetic Behavior of 14C-Poly (Methylmethacrylate) Nanoparticles in Experimental Tumor Models (2001) (43)
Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation. (2004) (43)
Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats. (2008) (43)
Long-term studies of microencapsulated and adsorbed influenza vaccine nanoparticles. (1981) (43)
Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles. (2011) (43)
Use of Nanoparticles for Cerebral Cancer (2008) (42)
Phosphodiester and phosphorothioate oligonucleotide condensation and preparation of antisense nanoparticles. (2001) (42)
Influence of the particle size on the adjuvant effect of particulate polymeric adjuvants. (1986) (41)
Adsorption of obidoxime onto human serum albumin nanoparticles: Drug loading, particle size and drug release (2010) (41)
Improved peroral delivery of avarol with polybutylcyanoacrylate nanoparticles (1994) (41)
Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80 (2008) (41)
Molecular weights of poly(butyl cyanoacrylate) nanoparticles determined by mass spectrometry and size exclusion chromatography. (2005) (39)
Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution. (2005) (39)
Effect of nonionic surfactants on transdermal drug delivery: II. Poloxamer and poloxamine surfactants (1991) (39)
Effects of surfactants and polymers on advancing and receding contact angles (1986) (38)
Toxicological study of doxorubicin‐loaded PLGA nanoparticles for the treatment of glioblastoma (2019) (38)
Optimization of pilocarpine loading onto nanoparticles by sorption procedures (1986) (38)
Interaction of serum components with poly(methylmethacrylate) nanoparticles and the resulting body distribution after intravenous injection in rats. (1993) (36)
Molecular weights of polycyanoacrylate nanoparticles (1983) (36)
Correlation of the surface hydrophobicity of 14C-poly(methyl methacrylate) nanoparticles to their body distribution (1992) (35)
Physico-chemical characterisation of cationic DOTAP liposomes as drug delivery system for a hydrophilic decapeptide before and after freeze-drying. (2012) (35)
Polybutylcyanoacrylate nanoparticles for the delivery of [75Se]norcholestenol (1983) (35)
Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction. (2005) (34)
The effects of polyalkylcyanoacrylate nanoparticles on human normal and malignant mesenchymal cells in vitro (1987) (34)
Enhanced transport of nanoparticle associated drugs through natural and artificial membranes--a general phenomenon? (1999) (34)
Biodegradable human serum albumin nanoparticles as contrast agents for the detection of hepatocellular carcinoma by magnetic resonance imaging. (2014) (31)
On the mechanism of termination in heterogeneous polymerization (1982) (30)
Improved delivery of methoxsalen. (1979) (30)
Mode of action of immunological adjuvants: some physicochemical factors influencing the effectivity of polyacrylic adjuvants (1978) (30)
Bovine seminal ribonuclease attached to nanoparticles made of polylactic acid kills leukemia and lymphoma cell lines in vitro (2000) (30)
Freeze-drying of HI-6-loaded recombinant human serum albumin nanoparticles for improved storage stability. (2014) (29)
Ocular therapeutics and drug delivery (1997) (29)
Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells (2011) (28)
Influence of Chitosan Microspheres on the Transport of Prednisolone Sodium Phosphate Across HT-29 Cell Monolayers (2004) (28)
Drug and vehicle deposition from topical applications: use of in vitro mass balance technique with minoxidil solutions. (1992) (27)
Use of isothermal heat conduction microcalorimetry to evaluate stability and excipient compatibility of a solid drug (1998) (27)
Investigation of polymer and nanoparticle properties with nicotinic acid and p-aminobenzoic acid grafted on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) via click chemistry. (2011) (26)
Toxicity and association of polycyanoacrylate nanoparticles with hepatocytes. (1984) (26)
Cationic lipid-protamine-DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides. (2005) (25)
Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging. (2015) (25)
Physicochemical characterization of protamine-phosphorothioate nanoparticles (2004) (25)
Intradermal air pouch leukocytosis as an in vivo test for nanoparticles (2013) (24)
Enteric coating derived from marine sponge collagen (2009) (23)
The use of 60Co-γ-irradiation for the production of vaccines (1978) (23)
Nanoparticles as drug carriers in ophthalmology. (1987) (23)
Crystallisation of estradiol containing TDDS determined by isothermal microcalorimetry, X-ray diffraction, and optical microscopy. (2003) (23)
Functionalized (poly(ɛ-caprolactone))₂-poly(ethylene glycol) nanoparticles with grafting nicotinic acid as drug carriers. (2012) (23)
Nanoparticle‐based delivery of carbamazepine: A promising approach for the treatment of refractory epilepsy (2018) (22)
Potential of surfactant‐coated nanoparticles to improve brain delivery of arylsulfatase A (2017) (22)
Enhanced antisense efficacy of oligonucleotides adsorbed to monomethylaminoethylmethacrylate methylmethacrylate copolymer nanoparticles. (2000) (21)
Development of nanoparticle-bound arylsulfatase B for enzyme replacement therapy of mucopolysaccharidosis VI. (2013) (21)
Determination of the physical state of norethindrone acetate containing transdermal drug delivery systems by isothermal microcalorimetry, X-ray diffraction, and optical microscopy. (2004) (21)
Pharmacological activity of DTPA linked to protein-based drug carrier systems. (2004) (21)
Distribution of polyhexylcyanoacrylate nanoparticles in nude mice over extended times and after repeated injection. (1988) (20)
Physico-chemical and toxicological characterization of iron-containing albumin nanoparticles as platforms for medical imaging. (2014) (20)
Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part I: Synthesis of monomers, dependence of the physical properties on the polymerization methods. (1999) (20)
Characterisation and stability studies of a hydrophilic decapeptide in different adjuvant drug delivery systems: a comparative study of PLGA nanoparticles versus chitosan-dextran sulphate microparticles versus DOTAP-liposomes. (2011) (19)
Human Serum Albumin-Based Nanoparticle-Mediated In Vitro Gene Delivery (2014) (19)
Particulates (Nanoparticles and Microparticles) (1993) (19)
Survivin-miRNA-loaded nanoparticles as auxiliary tools for radiation therapy: preparation, characterisation, drug release, cytotoxicity and therapeutic effect on colorectal cancer cells (2012) (19)
Incorporation of obidoxime into human serum albumin nanoparticles: optimisation of preparation parameters for the development of a stable formulation (2010) (18)
Hydroxyurea-Loaded Albumin Nanoparticles: Preparation, Characterization, and In Vitro Studies (2019) (17)
Physicochemical characterisation of cationic polybutylcyanoacrylate-nanoparticles by fluorescence correlation spectroscopy. (2004) (16)
Using Nanoparticles to Target Drugs to the Central Nervous System (2000) (15)
Encapsulation of water-insoluble drugs in poly(butyl cyanoacrylate) nanoparticles. (2009) (15)
Influence of HIV-infection on the phagocytic activity of monocytes/macrophages and granulocytes. (1994) (14)
Coupling of the antitumoral enzyme bovine seminal ribonuclease to polyethylene glycol chains increases its systemic efficacy in mice (2002) (14)
Effect of glycerol-L-lactide coating polymer on bone ingrowth of bFGF-coated hydroxyapatite implants. (2004) (14)
[10] Poly(alkyl acrylate) nanoparticles (1985) (13)
Dihydroxythiophenes Are Novel Potent Inhibitors of Human Immunodeficiency Virus Integrase with a Diketo Acid-Like Pharmacophore (2006) (12)
Penetration of spin-labeled retinoic acid from liposomal preparations into the skin of SKH1 hairless mice measurement by EPR tomography (1993) (12)
Increased Numbers of Injections of Doxorubicin Bound to Nanoparticles Lead to Enhanced Efficacy Against Rat Glioblastoma 101/8 (2009) (12)
Influence of Chronobiology on the Nanoparticle-Mediated Drug Uptake into the Brain (2015) (12)
Effect of ultrasonication on the stability of oligonucleotides adsorbed on nanoparticles and liposomes. (1999) (12)
Towards hybrid biocompatible magnetic rHuman serum albumin-based nanoparticles: use of ultra-small (CeLn)3/4+ cation-doped maghemite nanoparticles as functional shell (2015) (12)
Molecular weights of poly(methyl methacrylate) nanoparticles (1982) (11)
Use of isothermal heat conduction microcalorimetry, X-ray diffraction, and optical microscopy for characterisation of crystals grown in steroid combination-containing transdermal drug delivery systems. (2004) (11)
Nanoparticulate Carriers for Drug Delivery to the Brain (2006) (11)
Large-scale production problems and manufacturing of nanoparticles (1990) (11)
Protection induced by inactivated influenza virus vaccines with polymethylmethacrylate adjuvants (1978) (11)
Neuroprotective Activity of a Nanoparticulate Formulation of the GlycineB Site Antagonist MRZ 2/576 in Transient Focal Ischaemia in Rats (2002) (10)
Degradation of microvascular brain endothelial cell beta-catenin after co-culture with activated neutrophils from patients undergoing cardiac surgery with prolonged cardiopulmonary bypass. (2005) (10)
The use of isothermal heat conduction microcalorimetry to evaluate drug stability in tablets. (1999) (10)
Transdermal delivery of the tetrapeptide hisetal (melanotropin (6–9)) and amino acids: their contribution to the elucidation of the existence of an ‘aqueous pore’ pathway (1994) (9)
Delivery of liposome membrane-associated sterols through silastic membranes. (1981) (9)
Poly(Methyl Methacrylate) Nanoparticles As Vaccine Adjuvants (2000) (8)
Liberation of lithium from sustained release preparations. A comparison of seven registered brands. (1994) (8)
Glycerol-l-lactide coating polymer leads to delay in bone ingrowth in hydroxyapatite implants. (2005) (8)
Interaction of rubber closures with powders for parenteral administration. (1990) (7)
Contrast Enhancement of the Brain by Folate-Conjugated Gadolinium–Diethylenetriaminepentaacetic Acid–Human Serum Albumin Nanoparticles by Magnetic Resonance Imaging (2012) (7)
Cytotoxicity of aphidicolin and its derivatives against neuroblastoma cells in vitro: synergism with doxorubicin and vincristine (2000) (7)
Fluorescently Labeled PLGA Nanoparticles for Visualization In Vitro and In Vivo: The Importance of Dye Properties (2021) (6)
Preparation of SUV-liposomes by high-pressure homogenization (1993) (6)
Nanoparticles as a Potential Antigen Delivery System (1994) (5)
Radiation sterilization of medicinal formulations of doxorubicin bound to poly(butylcyanoacrylate) nanoparticles (2008) (5)
In vivo distribution of 125I-radiolabelled solid lipid nanoparticles (2006) (4)
Antiviral and immunomodulatory activity of the metal chelator ethylenediaminedisuccinic acid against cytomegalovirus in vitro and in vivo. (2002) (4)
Carrier-Mediated Antiviral Therapy (1988) (4)
Nanoparticles as Potent Adjuvants for Vaccines (1993) (4)
In vitro Antiviral Activity of Aphidicolin and its Derivates (2002) (4)
The influence of coatings with surfactants on the body distribution of nanoparticles after intravenous injection to rats (1993) (4)
Do Ultra-Low Frequency ULF) Magnetic Fields Affect the Blood-Brain Barrier? (1999) (4)
Arylsulfatase A bound to poly(butyl cyanoacrylate) nanoparticles for enzyme replacement therapy--physicochemical evaluation. (2014) (4)
Xenograft Model for Identifying Chemotherapeutic Agents against Papillomaviruses (2001) (3)
Antibiotic-impregnated heart valve sewing rings for treatment and prophylaxis of bacterial endocarditis (1996) (3)
Recent Advances in Nanoparticles and Nanospheres (1998) (3)
Nanoparticles — Preparation and Applications (2020) (3)
Historical Perspectives Nanoparticles — a historical perspective (2010) (3)
Production of nanoparticles: polymerization termination and molecular weights during radical-induced emulsifier-free emulsion polymerization (heterogeneous polymerization) (1998) (2)
The potential of polymeric nanoparticles to increase the immunogenicity of the hapten clenbuterol (1997) (2)
Nanoparticles – Colloidal Delivery Systems for Drugs and Vaccines (2005) (2)
Content/container interactions: The phenomenon of haze formation on reconstitution of solids for parenteral use (1991) (2)
Sorption of 5-fluorouracil from aqueous solutions onto methyl methacrylate nanoparticles. (1986) (2)
[Optimization of "Photosens" pharmakokinetics by biodegradable nanospheres]. (2001) (2)
Ocular disposition of carbon 14 polyhexyl 2 cyanoacrylate nanoparticles in the albino rabbit (1985) (1)
Poly(alkyl acrylate) nanoparticles. (1985) (1)
Coating of Nanoparticles with Surfactants: Targeting versus Prolonged Circulation (1998) (1)
DNA from bovine papillomavirus type 2 induces warts in a xenograft model. (2002) (1)
Influence of volatile rubber stopper components on the clearness of parenteral antibiotics stored in multiple or single dose containers after reconstitution with water (1994) (1)
A two-step procedure for the selection of a suitable rubber stopper for use with parenteral containiners (1995) (1)
Drug-loaded nanoparticles based on hydrophilic proteins (2006) (1)
Guest Editorial: Special Issue for Prof. Dr. Peter Paul Speiser (2009) (1)
P235 Blood-brain barrier permeability enhancement by surfactant coated nanoparticles (1994) (1)
Analgesic activity of loperamid- and tetrapeptidamid-loaded nanoparticles (1995) (0)
Magnetic and radiolabeled biodegradable nanoparticles for dual medical imaging (2014) (0)
PDT Journal Reviewers in 2002 (2003) (0)
Nanoscale Technology in Biological Systems, Ralph S. Greco, Fritz B. Prinz, R. Lane Smith (Eds.). CRC Press, Baca Raton, USA) 512 pages, (2005), $ 159,95, ISBN: 0-8493-1940-4 (2006) (0)
A process for preparing an adsorbed vaccine (1976) (0)
Pharmacophore Virus Integrase with a Diketo Acid-Like Inhibitors of Human Immunodeficiency Dihydroxythiophenes Are Novel Potent (2006) (0)
EÄ ec t of ultrason ication on th e stability of oligonu cle otide s ad sorbed on n an oparticle s an d liposom es (1999) (0)
Delivery of Liposome-Encapsulated Agents to Artificial Membranes (1992) (0)
Across the blood-brain barrier: Nanoparticles (2016) (0)
Uptake and Degradation of Protein Nanoparticles in Cerebellar Granular Cells (2013) (0)
Polymeric nanosystems for the delivery of antitumor and antituberculosis drug preparations (2013) (0)
Native collagen sponge, to processes for its isolation and its use, as well as native nanoparticulate collagen sponge, process for its preparation and its use (2000) (0)
Drug delivery to the brain using nanoparticles: A new therapeutic platform (2015) (0)
JÖRG KREUTER , INSTITUTE OF PHARMACEUTICAL TECHNOLOGY Nanoparticles as Drug Carriers DRUG TARGETING OF DRUGS AND NUCLEIC ACIDS (2009) (0)
Poly (Methyl Methacrylate) (PMMA) and Polyactic Acid Nanoparticles as Adjuvents for Peroral Vaccines (1999) (0)
Nanoparticulate doxorubicin for systemic chemotherapy intracranial gliobblastoma (2000) (0)
Evaluation of cholesterol modified cationic lipids as liposomal carriers for antisense oligonucleotides (1999) (0)
The influence of air space during storage on the stability of drug mixtures (1999) (0)
Enteric device for release of mucoadhesive drug carriers and methods of making the enteric coating apparatus (2001) (0)
Nanoparticulate systems for brain delivery of oximes: First loading studies (2007) (0)
Antivirals against AIDS /edited by Ronald E. Unger and Jörg Kreuter, Helga Rübsamen-Waigmann (2000) (0)
Synthesis and characterization of polymeric nanoparticles based on albumin (2013) (0)
Nanoencapsulation of antitumor and antituberculosis drug preparations with biocompatible polymers (2014) (0)
New forms of anticance drugs «Arglabin» based on human serum albumin (2016) (0)
Nanoparticles protein apolipoprotein and coupled to overcome the blood brain barrier and method for its production. (2002) (0)
Uptake of new somatostatin analogue loaded recombinant human serum albumin nanoparticles in pancreatic carcinoma cells (2013) (0)
TARGETING VERSUS PROLONGED CIRCULATION (1998) (0)
The use of liquid media in kolloidoploselige or suspendible particles of physiologically tolerable polymer material in combination with the biologically active material (1976) (0)
P285 development of antibiotic-protected artificial heart valves (1994) (0)
Influence of purification of basis polymers used for rubber closures (1994) (0)
Influence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly nanoparticles (1992) (0)
Protein-based carrier system to overcome resistance of tumor cells (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jörg Prof. Dr. Kreuter?

Jörg Prof. Dr. Kreuter is affiliated with the following schools:

Jörg Prof. Dr. Kreuter's Academic­Influence.com Rankings

Why Is Jörg Prof. Dr. Kreuter Influential?

Jörg Prof. Dr. Kreuter's Published Works

Published Works

What Schools Are Affiliated With Jörg Prof. Dr. Kreuter?

Jörg Prof. Dr. Kreuter's AcademicInfluence.com Rankings